List of Tables
TABLE 1. GAUCHER DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY AMBROXOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY IMIGLUCERASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY TALIGLUCERASE ALFA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY VELAGLUCERASE ALFA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY ELIGLUSTAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY MIGLUSTAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY TYPE 1, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY TYPE 2, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY TYPE 3, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY GENERAL CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY NURSE ADMINISTERED, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY SELF ADMINISTERED, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GAUCHER DISEASE TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS GAUCHER DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. CANADA GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 68. CANADA GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 69. CANADA GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 70. CANADA GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 71. CANADA GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 72. CANADA GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. CANADA GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 74. CANADA GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 75. CANADA GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 76. CANADA GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 77. MEXICO GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 79. MEXICO GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 80. MEXICO GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 81. MEXICO GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. MEXICO GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 85. MEXICO GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 86. MEXICO GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 87. MEXICO GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 133. GERMANY GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 134. GERMANY GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 135. GERMANY GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 136. GERMANY GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 137. GERMANY GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 138. GERMANY GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 139. GERMANY GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. GERMANY GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 141. GERMANY GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 142. GERMANY GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 143. GERMANY GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 144. FRANCE GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 145. FRANCE GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 146. FRANCE GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 147. FRANCE GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 148. FRANCE GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 149. FRANCE GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 150. FRANCE GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. FRANCE GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 152. FRANCE GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 153. FRANCE GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 154. FRANCE GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 166. ITALY GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 167. ITALY GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 168. ITALY GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 169. ITALY GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 170. ITALY GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 171. ITALY GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 172. ITALY GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. ITALY GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 174. ITALY GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 175. ITALY GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 176. ITALY GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 177. SPAIN GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 178. SPAIN GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 179. SPAIN GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 180. SPAIN GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 181. SPAIN GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 182. SPAIN GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 183. SPAIN GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SPAIN GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 185. SPAIN GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 186. SPAIN GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 187. SPAIN GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 221. DENMARK GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 222. DENMARK GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 223. DENMARK GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 224. DENMARK GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 225. DENMARK GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 226. DENMARK GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 227. DENMARK GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. DENMARK GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 229. DENMARK GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 230. DENMARK GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 231. DENMARK GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 243. QATAR GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 244. QATAR GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 245. QATAR GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 246. QATAR GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 247. QATAR GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 248. QATAR GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 249. QATAR GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. QATAR GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 251. QATAR GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 252. QATAR GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 253. QATAR GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 254. FINLAND GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 255. FINLAND GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 256. FINLAND GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 257. FINLAND GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 258. FINLAND GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 259. FINLAND GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 260. FINLAND GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. FINLAND GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 262. FINLAND GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 263. FINLAND GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 264. FINLAND GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 265. SWEDEN GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 266. SWEDEN GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 267. SWEDEN GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 268. SWEDEN GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 269. SWEDEN GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 270. SWEDEN GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 271. SWEDEN GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. SWEDEN GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 276. NIGERIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 277. NIGERIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 278. NIGERIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 279. NIGERIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 287. EGYPT GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 288. EGYPT GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 289. EGYPT GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 290. EGYPT GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 291. EGYPT GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 292. EGYPT GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 293. EGYPT GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. EGYPT GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 295. EGYPT GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 296. EGYPT GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 297. EGYPT GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 298. TURKEY GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 299. TURKEY GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 300. TURKEY GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 301. TURKEY GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 302. TURKEY GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 303. TURKEY GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 304. TURKEY GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. TURKEY GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 306. TURKEY GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 307. TURKEY GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 308. TURKEY GAUCHER DISEASE TREATMENT MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 309. ISRAEL GAUCHER DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 310. ISRAEL GAUCHER DISEASE TREATMENT MARKET SIZE, BY CHAPERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 311. ISRAEL GAUCHER DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 312. ISRAEL GAUCHER DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2030 (USD MILLION)
TABLE 313. ISRAEL GAUCHER DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 314. ISRAEL GAUCHER DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
TABLE 315. ISRAEL GAUCHER DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. ISRAEL GAUCHER DISEASE TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 317. ISRAEL GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 318. ISRAEL GAUCHER DISEASE TREATMENT MARKET SIZE, BY HOSPITAL, 2018